ask="5.53"
ask_size="1000"
average_daily_volume="814600"
bid="3.30"
bid_size="1000"
book_value="5.03"
change="-0.05"
change_from_200_day_moving_average="1.05"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-4.11"
change_From_52_week_low="2.54"
change_in_percent="-1.18%"
close="4.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.70"
eps_estimate_next_quarter="-0.84"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="9420000"
high="4.24"
high_52_weeks="8.30"
last_trade_date="3/9/2017"
last_trade_price="4.19"
last_trade_size="1210"
last_trade_time="4:00pm"
low="4.13"
low_52_weeks="1.65"
market_capitalization="61.12M"
moving_average_200_day="3.14"
moving_average_50_day="4.11"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="10.00"
open="4.20"
pe_ratio="N/A"
peg_ratio="0.01"
percent_change_from_200_day_moving_average="+33.36%"
percent_change_from_50_day_moving_average="+2.05%"
percent_change_from_52_week_high="-49.52%"
percent_change_from_52_week_low="+153.94%"
previous_close="4.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.84"
price_per_sales="2.50"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="3.92"
stock_exchange="NMS"
symbol="OREX"
volume="78233"
weeks_range_52="1.65 - 8.30"
